MANÜ Telehealth sells a product it names Compounded Semaglutide and prints a benefits tile headed FDA-Approved on the same page. Compounded drugs are not FDA-approved, and the contradiction is the seller's own, in its own words.
What MANÜ Telehealth charges
MANÜ Telehealth does not publish a price today.
MANÜ Telehealth is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
The claim, and where it sits
The page is titled with the word compounded. Its opening paragraph names the product as compounded and, in the same sentence, describes it as approved for chronic weight management.
Further down, a benefits tile is headed with a tick and the words FDA-Approved, and says the product is approved for chronic weight management and type 2 diabetes, backed by extensive clinical trials.
Those statements are true of the branded, approved product. They are not true of a compounded preparation, which by definition has not been through that approval.
Why this record quotes it rather than corrects it
This site records what a seller says about the legal category of what it sells, in the seller's own words, and does not paraphrase it into something safer.
Nothing here endorses the claim. It is recorded because a reader deciding between sellers is entitled to know that this one describes a compounded product as an approved one.
The distinction matters in practice: it is the difference between a medicine reviewed by a regulator and one prepared to a prescription without that review.
No price, in either language
Both weight-loss product pages exist in English and in Spanish, which is worth crediting on a roster where almost nothing is bilingual.
Neither language version carries a figure. There is no price on this record for that reason.
The pages do publish eligibility thresholds and a dose-escalation description, which is more than a bare marketing page.
The rest of the record
A telephone number and an email address are published in the footer.
No state list is published and no dispensing pharmacy is named.
No certificate of analysis is reachable. A meaningless address on this host returns a not-found response, so those absences are absences.
Who it's for
Readers who want to see how a compounded product can be described as an approved one.
Buyers who want product pages in Spanish as well as English.
Shoppers who want the eligibility thresholds published before an intake.
Anyone comparing how sellers describe the legal category of what they sell.
Who should look elsewhere
Readers who want a price before starting.
Buyers who need a clear statement that a compounded drug is not approved.
Anyone who needs a published state list or a named pharmacy.
Shoppers who require reachable testing documents.
Strengths
Publishes the same product pages in English and in Spanish rather than only one
Names the eligibility criteria it applies — a body-mass index threshold, and a lower one with weight-related conditions
Publishes a telephone number and an email address in its footer
Describes the dose-escalation schedule rather than only the starting dose
Trade-offs
Prints a benefits tile headed FDA-Approved on a page selling a compounded product
Publishes no price on either product page, in either language
Publishes no state list and names no dispensing pharmacy
No certificate of analysis is reachable
How we verified this
Read the product page in full and recorded the approval claim from the seller's own paragraph and its own benefits tile, rather than paraphrasing it.
Checked both the English and the Spanish versions of both weight-loss pages for a figure and found none.
Recorded no price and set the published-price flag to false.
Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
Screened the brand against the live federal warning-letter table, filtering locally because the table's own search parameter returns every record whatever is typed into it, with a positive and a nonsense control in the same run.
A provider to compare MANÜ Telehealth against
Lavender Sky Health
Lavender Sky Health publishes a price for every peptide it sells against the specific pharmacy that would fill it — nine pharmacies named, quantity by quantity — and states plainly that none of those figures includes the consultation fee it prices separately.
No. A compounded preparation is made to a prescription and has not been through the approval that a branded product has. This seller's page says otherwise.
Is that claim a warning letter or a finding?
Neither. It is what the page says, recorded here as the seller's own words. No federal letter is attached to this company.
What does it cost?
The site does not say. Neither the English nor the Spanish version of either product page carries a figure.
Who can be prescribed it?
The page publishes body-mass-index thresholds — one on its own, and a lower one where weight-related conditions are present.
MANÜ Telehealth is not a paid partner; this link may earn a commission if that changes. Full disclosure.